HU185224B - Process for preparing 1-/8-quinolyl/-2-pyrrolidinone and acid addition salts thereof - Google Patents
Process for preparing 1-/8-quinolyl/-2-pyrrolidinone and acid addition salts thereof Download PDFInfo
- Publication number
- HU185224B HU185224B HU802850A HU285080A HU185224B HU 185224 B HU185224 B HU 185224B HU 802850 A HU802850 A HU 802850A HU 285080 A HU285080 A HU 285080A HU 185224 B HU185224 B HU 185224B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compound
- priority
- quinolyl
- pyrrolidinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7941409 | 1979-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU185224B true HU185224B (en) | 1984-12-28 |
Family
ID=10509524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU802850A HU185224B (en) | 1979-11-30 | 1980-11-28 | Process for preparing 1-/8-quinolyl/-2-pyrrolidinone and acid addition salts thereof |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4366158A (enExample) |
| EP (1) | EP0030023A3 (enExample) |
| JP (1) | JPS5699475A (enExample) |
| KR (1) | KR830004293A (enExample) |
| AR (1) | AR228442A1 (enExample) |
| AT (1) | AT375363B (enExample) |
| AU (1) | AU6495080A (enExample) |
| CA (1) | CA1156235A (enExample) |
| DK (1) | DK506480A (enExample) |
| ES (1) | ES8203882A1 (enExample) |
| FI (1) | FI803704L (enExample) |
| GB (1) | GB2063868B (enExample) |
| GR (1) | GR71918B (enExample) |
| HU (1) | HU185224B (enExample) |
| IL (1) | IL61580A (enExample) |
| IT (1) | IT1221040B (enExample) |
| NZ (1) | NZ195688A (enExample) |
| ZA (1) | ZA807467B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1558582T3 (pl) | 2003-07-22 | 2006-05-31 | Arena Pharm Inc | Diarylowe i aryloheteroarylowe pochodne mocznika jako modulatory receptora serotoninowego 5-HT2A użyteczne w profilaktyce i w leczeniu zaburzeń związanych z tym receptorem |
| GB0507198D0 (en) * | 2005-04-08 | 2005-05-18 | Sb Pharmco Inc | Process for preparing bicyclic compounds |
| GB0519758D0 (en) * | 2005-09-28 | 2005-11-09 | Glaxo Group Ltd | Novel process |
| US9084742B2 (en) | 2007-12-12 | 2015-07-21 | Axovant Sciences Ltd. | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
| MX388281B (es) | 2015-06-12 | 2025-03-11 | Axovant Sciences Gmbh | Derivados de diaril y arilheteroaril urea como moduladores del receptor 5ht2a de serotonina útiles para la profilaxis y el tratamiento de un trastorno conductual del sueño rem. |
| CA2992518A1 (en) | 2015-07-15 | 2017-01-19 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
-
1980
- 1980-11-24 US US06/209,426 patent/US4366158A/en not_active Expired - Lifetime
- 1980-11-26 GB GB8037872A patent/GB2063868B/en not_active Expired
- 1980-11-28 ES ES497242A patent/ES8203882A1/es not_active Expired
- 1980-11-28 KR KR1019800004552A patent/KR830004293A/ko not_active Withdrawn
- 1980-11-28 AU AU64950/80A patent/AU6495080A/en not_active Abandoned
- 1980-11-28 GR GR63493A patent/GR71918B/el unknown
- 1980-11-28 AT AT0582780A patent/AT375363B/de not_active IP Right Cessation
- 1980-11-28 IT IT50277/80A patent/IT1221040B/it active
- 1980-11-28 ZA ZA00807467A patent/ZA807467B/xx unknown
- 1980-11-28 AR AR283420A patent/AR228442A1/es active
- 1980-11-28 CA CA000365722A patent/CA1156235A/en not_active Expired
- 1980-11-28 FI FI803704A patent/FI803704L/fi not_active Application Discontinuation
- 1980-11-28 IL IL61580A patent/IL61580A/xx unknown
- 1980-11-28 JP JP16791880A patent/JPS5699475A/ja active Pending
- 1980-11-28 DK DK506480A patent/DK506480A/da not_active Application Discontinuation
- 1980-11-28 HU HU802850A patent/HU185224B/hu unknown
- 1980-11-28 EP EP80107463A patent/EP0030023A3/en not_active Ceased
- 1980-11-28 NZ NZ195688A patent/NZ195688A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT375363B (de) | 1984-07-25 |
| IT1221040B (it) | 1990-06-21 |
| IL61580A (en) | 1984-06-29 |
| IT8050277A0 (it) | 1980-11-28 |
| DK506480A (da) | 1981-05-31 |
| ES497242A0 (es) | 1982-04-01 |
| ES8203882A1 (es) | 1982-04-01 |
| GR71918B (enExample) | 1983-08-17 |
| AR228442A1 (es) | 1983-03-15 |
| FI803704A7 (fi) | 1981-05-31 |
| IL61580A0 (en) | 1980-12-31 |
| EP0030023A3 (en) | 1981-09-02 |
| KR830004293A (ko) | 1983-07-09 |
| ATA582780A (de) | 1983-12-15 |
| JPS5699475A (en) | 1981-08-10 |
| NZ195688A (en) | 1984-09-28 |
| EP0030023A2 (en) | 1981-06-10 |
| GB2063868A (en) | 1981-06-10 |
| FI803704L (fi) | 1981-05-31 |
| US4366158A (en) | 1982-12-28 |
| CA1156235A (en) | 1983-11-01 |
| GB2063868B (en) | 1984-02-29 |
| AU6495080A (en) | 1981-06-04 |
| ZA807467B (en) | 1982-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6254792B2 (enExample) | ||
| IE57633B1 (en) | 2-amino-5-hydroxy-4-methylpyrimidine derivatives | |
| JPS647997B2 (enExample) | ||
| JPH0415786B2 (enExample) | ||
| KR850000216B1 (ko) | 피페라진 유도체의 제조방법 | |
| US4344943A (en) | 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof | |
| SA95160203B1 (ar) | مشتقات بيرولوكربازول كيميائية علاجية Chemotheraqeutic Pyrrolocarbazole Derivatives | |
| JPH0625091B2 (ja) | ジヒドロジベンゾシクロヘプチリデン―エチルアミン誘導体その製法ならびに医薬組成物 | |
| HU185224B (en) | Process for preparing 1-/8-quinolyl/-2-pyrrolidinone and acid addition salts thereof | |
| JPS6254109B2 (enExample) | ||
| EP4592287A1 (en) | 2h-benzotriazole derivative, preparation method therefor, and pharmaceutical composition containing same | |
| EP0350878B1 (en) | Conjugated gamma-oxybutenolide compounds for treating ulcer | |
| JPS601310B2 (ja) | イミダゾリン化合物の製法 | |
| JP2726999B2 (ja) | イミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤 | |
| JP2790335B2 (ja) | 共役γ―オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤 | |
| EP0362299A1 (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
| JPS6241234B2 (enExample) | ||
| JP2658198B2 (ja) | ピラノベンゾトリアゾール誘導体 | |
| US4087549A (en) | Sulphonic acid containing indenyl derivatives | |
| EP0058009A1 (en) | Novel benzanilide derivatives and pharmaceutical compositions containing them | |
| JPH0680041B2 (ja) | ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬 | |
| US3676439A (en) | 5,6-dihydro-8,8-dimethyl-3-nitro-8h imidazo(2-1-c) (1,4)oxazine | |
| JP2678768B2 (ja) | テトラヒドロイミダゾ［２，１−ｂ］ベンゾチアゾール誘導体及び該化合物を有効成分とする抗潰瘍剤 | |
| JPS6131105B2 (enExample) | ||
| US4172145A (en) | Benzo(b)furylacetic acid derivatives to reduce inflammation |